1 / 97

Movement Disorders

Movement Disorders. Tory Davis PA-C UNE PA Program. Tremor Classification. Rest vs Action Body part(s) affected Frequency- how fast, measured in hertz (cycles/second) Amplitude- fine or coarse. Resting Tremor.

Download Presentation

Movement Disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.


Presentation Transcript

  1. Movement Disorders Tory Davis PA-C UNE PA Program

  2. Tremor Classification • Rest vs Action • Body part(s) affected • Frequency- how fast, measured in hertz (cycles/second) • Amplitude- fine or coarse

  3. Resting Tremor • Body part affected is supported against gravity, no muscle contraction (hands in lap) • Amplitude •  with mental stress •  with general mvmt (walking) •  with target directed mvmt (finger to nose)

  4. Action Tremor • Produced by voluntary muscle contraction • 1. Postural- body part maintaining position against gravity • 2. Isometric- muscle contraction against stationary object (finger squeeze) • 3. Kinetic-with voluntary mvmt

  5. Kinetic subtypes • Simple kinetic tremor- assoc with mvmt of extremities (pronate/supinate) • Intention tremor- present during visually-guided, target-directed motion.  amplitude fluctuation on approaching target (finger to nose)

  6. Physiologic tremor • Every “normal” person has a • High frequency, low amplitude postural tremor • Enhanced by hyper-adrenergic states: hypoglycemia, thyrotoxicosis, drugs (caffeine), withdrawal, public speaking

  7. Benign Essential Tremor • aka benign familial tremor • Most common movement disorder worldwide • Prevalence reported up to 5% of people over 60- BUT, half of people with mild essential tremor aren’t aware • FHx reports vary (20-60%)

  8. Essential tremor • Insidious development, slow progression • 95% start w/ postural distal arm tremor • Wrist flex/ext , 4-12 Hz frequency • Bimodal onset: teens and 50s • Unilateral progresses to bilateral • UE, head (yes or no), palate (rare) • Legs usually spared

  9. Essential tremor • Amplitude •  with stress, fatigue, CNS stimulants, voluntary activity •  with EtOH, ß-blockade, rest

  10. Pt Ed • Avoid stimulants • Avoid fatigue • Avoid stress • …and don’t self-medicate with alcohol

  11. Tx: Primidone • Primidone 50-750 mg/day. Anticonvulsant. Start at 25mg qhs and slowly titrate up to avoid sedation. • Contraindicated in asthma • SEs: sedation, dizziness, nausea, mood changes

  12. Tx: Beta blocker • ß- Blockade: Propranolol 40-320 mg/day. Better tolerated, no more effective than primidone • Contraindicated in asthma, bradycardia, cardiac conduction defects • SEs: sexual side effects, fatigue, depression

  13. Parkinson’s Disease

  14. What it is • Neurodegenerative disorder resulting from  dopaminergic transmission in basal ganglia

  15. Parkinson’s Disease-4 Cardinal Signs • Tremor • Rigidity • Bradykinesia (slowness of movement) • Postural impairment (comes later in ds)

  16. PD Tremor • Present in 85% • 4-6 Hz resting tremor • Distal, unilateral “pill-rolling” •  by voluntary activity,  by stress • One limb or one side of body for months to years • Spares head

  17. PD Rigidity • Increased resistance to passive movements • “Cogwheel rigidity” • No weakness • No change in DTRs

  18. Bradykinesia • Slowness of movements • Noticed in speech as well as voluntary movements • Start hesitation

  19. Postural impairment • Difficulty with balance and gait • Occurs later in disease course. • If you see this early, question dx and refer to neuro

  20. Gait • Classic “festinating gait” • Flexed trunk. Legs and hips stiff and flexed. • Arms still (not swinging) • Short fast steps- trying to keep up with the forward center of gravity • Turn “en bloc” • Later in disease, freezing w/ direction change or when entering small space (doorway)

  21. “Mask-like” face Widened palpebral fissures Decreased blinking Seborrhea scalp or face Dementia 6x nl population- AD in 40%  rapid alt mvmts “Freezing”/akinesia Sialorrhea Depression Micrographia Hypophonia Dystonia Other features

  22. Epidemiology • >1 million in US, 50k new cases yearly • Estimates of 400% increase in coming decades • Peak onset 60 (35-85) • Course 10-25 years • Male > female • Some genetic predisposition

  23. Risk factors • + FHx (5-10%) • Male gender • Pesticide exposure • Head trauma • Rural living • Well water

  24. Reduced Risk • Coffee drinking • Smoking • NSAID use • Estrogen replacement in post-menopausal women

  25. Parkinson’s Dz Pathophysiology • Loss of melanin-containing, dopaminergic neurons in substantia nigra • Lewy bodies- protein lint balls. Pathological hallmark of PD when in basal ganglia, but also seen in other disease states

  26. Diagnosis • Difficult! Clinical! • No lab test • No biomarker • And by the time symptoms appear, dopamine depleted by 70%

  27. Clinical Dx • Progressive, slow unfolding of characteristic PD s/s during the first few years after onset of sx • Can confirm dx postmortem • Not helpful • Suspect and refer

  28. Make the case • Presenting sx: C/o difficulty with dressing, cutting food, writing, getting in/out of car, feeling stiff. Spouse notes slowness, blank face • 1st visit- usually after 1-2 years of minor changes • Check the hx: gradual worsening, fhx of neuro disorder, drug use, hx encephalitis, toxic exposure

  29. Office exam I • Tremor- resting, not action. Test it. • How? • Rigidity- Check passive ROM. Feel for mechanical, ratchet-like sensation • Bradykinesia- watch her get out of chair, write*. • *(BET- large, shaky scrawl; PD- micrographia)

  30. Office Exam II • Impaired postural reflexes- gait testing- walk away, pivot and return. PD will take extra turning steps. • Pull test. Stand behind and (with warning) pull back on pt. Nl- stops potential fall in 1-2 steps. Be braced to help.

  31. NOT PD? • No response to levodopa • Symmetrical, bilateral at onset • Rapid progression, including early falls • Dysautonomia: incontinence, orthostatic hypotension, urinary retention • Early cognitive defects • Abnormal eye movements

  32. Drug induced parkinsonism Progressive supranuclear palsy Alzheimer’s disease Normal pressure hydrocephaly Wilson’s Depression Multiple system atrophy Dementia with diffuse Lewy body disease Multi-infarct parkinsonism Huntington’s Essential tremor Differential Dx

  33. PD Treatment • No proven clinically neuroprotective drug. But that’s the goal… • Start tx when functional disability starts. Varies based on multiple factors. • Goals: maintain function and QOL, avoid drug-induced complications • (Do no harm.)

  34. PD Tx- Dopamine • Levodopa- Gold Standard. Converted to dopamine in brain. (Dopamine itself can’t cross blood/brain barrier.) • Improves all features of PD, but wears off over time • Think “Awakenings”

  35. Dopamine • First line for years, but now primarily second line due to • Side effects (see next slide) • Wearing off • Hypothetical (?) concern that free radicals generated by the oxidative metabolism of dopamine contribute further to the degeneration of dopaminergic neurons

  36. Dopamine Side Effects • Nausea • Wearing off-when effects of single dose don’t last as long • Dyskinesias- sudden, uncontrollable, jerky movements of arms, legs, head, trunk • On/off response- due to fluctuating levels of dopa • On-  uncontrolled movements • Off-  motion, freezing

  37. Add-on meds • Dopamine plus…. • Carbidopa- (decarboxylase inhibitor) • Entacapone (COMT inhibitor, inhibits break down of catecholamines) • Purpose: decreased levodopa breakdown/conversion in bloodstream, maximizes delivery to brain, minimizes nausea

  38. Dopamine agonists • Maybe some neuroprotection • Behave like dopamine by stimulating dopamine receptor directly • Can be used as initial monotherapy (first line) to preserve use of dopamine for later in disease course • Add-on to dopamine when levodopa alone no longer effective (or SEs intolerable) • Side effect of sudden-onset sleepiness

  39. Dopamine agonists • Bromocriptine (Parlodel) • Pergolide (Permax) • Pramipexole (Mirapex) • Ropinirole (Requip) • Apomorphine- (Apokyn) injectable, rapid-acting, “rescue” med for acute freezing episodes. SE: severe n/v

  40. Anticholinergics • Primarily to alleviate tremor. (Balances acetylcholine and dopamine.) • Trihexylphenidyl (Artane), benztropine (Cogentin) • SE- dry mouth, nausea, constipation, palpitations, arrhythmias, urine retention • Contraindications- BPH, narrow angle glaucoma, obstructive GI disease • Poorly tolerated by elderly

  41. Amantidine • Antiviral flu drug, also anti-dyskinetic for mild symptoms • ? MOA • SEs: restlessness, confusion, rash, edema, nausea, cardiac arrhythmias

  42. MAO-B inhibitor • Monoamine Oxidase type B Inhibitor Selegiline, rasagiline (also used in Alzheimer’s) •  dopa breakdown, may  dopamine reuptake • Modest effect for mild sx, reduces “off” time • May be neuroprotective • SE- confusion, nausea, headache, insomnia

  43. Antioxidants • Depleted in PD patients. May be neuroprotective. • Glutathione • Coenzyme Q • Ongoing studies for these relatively new treatments

  44. DBS • Deep Brain Stimulation • Surgically implanted neurostimulator in subthalamic nucleus • Blocks abnormal signals that cause PD sx • Only for pts whose sx are uncontrolled by medications

  45. Future/Research • Research into causation • Toxic • Environmental • Genetic • Research into treatment • Neuroprotection • Meds to delay, prevent, or reverse effects of disease

  46. Huntington’s Disease

  47. Definition • Autosomal dominant neurodegenerative disorder. • Triad of motor, cognitive and psychiatric symptoms • Insidious onset, no cure • Age of onset of sx 30-50, usually after people have reproduced • Fatal in 15-20 years

  48. Movement disorder • Presence of involuntary movements • Impairment of voluntary movements • Catch 22: Tx of involuntary can worsen impairment of voluntary, and impairment of voluntary movements is correlated with functional disability

  49. Involuntary movements • Chorea- “the dance” Primary invol mvmt in HD • Athetosis- proximal limb writhing • Hemiballismus- violent, proximal limb flinging

  50. Chorea • Involuntary, irregular, rapid, uncontrolled, excessive movement • Stark contrast to paucity of movement in Parkinson’s • Seem to move randomly from one body part to another • Appears to be almost playful, fidgety • Often not noticed by (nor disturbing to) the pt

More Related